Home
>
National Drug Code (NDC)
>
ETOPOPHOS
ETOPOPHOS - 0015-3404-20 - (etoposide phosphate)
Drug Information of ETOPOPHOS
| Product NDC: | 0015-3404 |
| Proprietary Name: | ETOPOPHOS |
| Non Proprietary Name: | etoposide phosphate |
| Active Ingredient(s): | 100 mg/1 & nbsp; etoposide phosphate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ETOPOPHOS
| Product NDC: | 0015-3404 |
| Labeler Name: | E.R. Squibb & Sons, L.L.C. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020457 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090601 |
Package Information of ETOPOPHOS
| Package NDC: | 0015-3404-20 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (0015-3404-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
NDC Information of ETOPOPHOS
| NDC Code | 0015-3404-20 |
| Proprietary Name | ETOPOPHOS |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0015-3404-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0015-3404 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | etoposide phosphate |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090601 |
| Marketing Category Name | NDA |
| Labeler Name | E.R. Squibb & Sons, L.L.C. |
| Substance Name | ETOPOSIDE PHOSPHATE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
